pre-seed
Stage
1
Investors
About
Thor Medical produces and supplies alpha-particle emitters derived from thorium (Th-232) for use in cancer therapy, focusing on a novel, efficient, and environmentally friendly production technology.
Explore Thor Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.